APVS: AI 评分 44/100 — AI 分析 (4月 2026)

Applied Visual Sciences, Inc. specializes in computer-vision detection solutions for aviation/homeland security and healthcare. Their technology aims to improve threat detection and diagnostic accuracy through advanced image processing.

Key Facts: AI Score: 44/100 Sector: Technology

公司概况

概要：

Applied Visual Sciences, Inc. develops computer-vision solutions for aviation security and healthcare, focusing on automated threat recognition and diagnostic imaging. Their Signature Mapping platform and PinPoint technology target critical needs in security and medical sectors, operating in a competitive software application landscape.

APVS是做什么的？

Founded in 1989 and based in Leesburg, Virginia, Applied Visual Sciences, Inc. (APVS) is a software technology company specializing in computer-vision detection solutions. Originally named Guardian Technologies International, Inc., the company rebranded in July 2010 to reflect its focus on advanced visual technologies. APVS designs and develops integrated information management technology products and services for corporations and governmental agencies, primarily targeting the aviation/homeland security and healthcare markets. Their core offerings include PinPoint, an intelligent computer-vision system for automated target recognition of threats like guns and explosives in baggage and building security. Additionally, APVS provides the Signature Mapping platform technology, which is used in diagnostic radiology and pathology. This platform underpins the Signature Mapping Detection System, a hardware-software solution for infectious disease applications, and specific software like Signature Mapping Tuberculosis Detection and Signature Mapping Breast Cancer Detection. APVS markets its products globally through direct sales and indirect distribution channels.

APVS的投资论点是什么？

Applied Visual Sciences, Inc. operates in niche markets within the security and healthcare sectors, leveraging computer-vision technology. With a market capitalization of $0.00B and a negative P/E ratio of -0.01, the company's financial performance is currently challenged. The company's beta of -10.35 suggests high volatility relative to the market. Growth catalysts depend on successful commercialization of their Signature Mapping platform and PinPoint technology. Key risks include limited financial resources, intense competition, and the need for regulatory approvals. Investors should closely monitor the company's ability to secure contracts and expand its market presence.

APVS在哪个行业运营？

Applied Visual Sciences, Inc. operates in the software application industry, which is characterized by rapid technological advancements and intense competition. The market for computer-vision solutions in security and healthcare is growing, driven by increasing demand for automated threat detection and diagnostic accuracy. Key competitors include companies offering similar imaging and detection technologies. APVS's success depends on its ability to innovate and differentiate its products in this competitive landscape.

Software - Application

Technology

APVS有哪些增长机遇？

Expansion in Aviation Security: The increasing need for enhanced security measures at airports globally presents a significant growth opportunity for APVS's PinPoint technology. The market for aviation security systems is projected to reach billions of dollars by 2030. Securing contracts with major airports could drive substantial revenue growth for APVS.
Adoption in Healthcare Diagnostics: The Signature Mapping platform has the potential to revolutionize diagnostic radiology and pathology. As healthcare providers increasingly adopt AI-powered diagnostic tools, APVS can capitalize on the growing demand for accurate and efficient detection systems. The market for AI in healthcare diagnostics is expected to grow rapidly over the next decade.
Strategic Partnerships: Forming strategic alliances with established players in the security and healthcare industries can accelerate market penetration for APVS. Partnering with companies that have existing distribution channels and customer relationships can provide access to new markets and customers.
Government Contracts: Securing government contracts for homeland security applications can provide a stable revenue stream for APVS. Government agencies are increasingly investing in advanced security technologies to protect critical infrastructure and public spaces. APVS's PinPoint technology is well-suited for these applications.
International Expansion: Expanding into international markets can unlock new growth opportunities for APVS. The demand for advanced security and healthcare solutions is growing globally, particularly in emerging markets. Adapting its products to meet the specific needs of different regions can drive international sales.

Market Cap: $0.00B indicating a micro-cap company with limited financial resources.
P/E Ratio: -0.01 reflecting negative earnings and potential financial instability.
Beta: -10.35 suggesting high volatility and potential for significant price swings.
Dividend Yield: None indicating no current income for investors.
Focus on computer-vision detection solutions for aviation/homeland security and healthcare markets, positioning them in high-growth sectors.

APVS提供哪些产品和服务？

Develop computer-vision detection solutions.
Design software for aviation/homeland security.
Create imaging technologies for healthcare markets.
Offer PinPoint technology for threat detection.
Provide Signature Mapping platform for diagnostic radiology.
Offer Signature Mapping Detection System for infectious disease applications.

APVS如何赚钱？

Direct sales of software and hardware solutions.
Indirect distribution through channel partners.
Licensing of Signature Mapping platform technology.
Service and maintenance contracts for installed systems.

Airports and transportation security agencies.
Hospitals and diagnostic imaging centers.
Government agencies focused on homeland security.
Research institutions studying infectious diseases.

Proprietary computer-vision algorithms.
Patented Signature Mapping platform technology.
Specialized expertise in aviation security and healthcare diagnostics.
Established relationships with key customers and partners.

什么因素可能推动APVS股价上涨？

Ongoing: Potential contracts with airports for PinPoint technology.
Ongoing: Adoption of Signature Mapping platform in healthcare.
Upcoming: Potential strategic partnerships with industry players.
Upcoming: Securing government contracts for homeland security applications.

APVS的主要风险是什么？

Ongoing: Limited financial resources.
Potential: Intense competition from larger companies.
Potential: Rapid technological advancements.
Potential: Regulatory hurdles and compliance requirements.
Ongoing: Low trading volume and liquidity due to OTC listing.

APVS的核心优势是什么？

Proprietary computer-vision technology.
Focus on high-growth markets (security and healthcare).
Established Signature Mapping platform.
Specialized expertise in target recognition and diagnostic imaging.

APVS的劣势是什么？

Limited financial resources.
Small employee base (3 employees).
Dependence on a few key products.
Negative P/E ratio indicating unprofitability.

APVS有哪些机遇？

Expansion into new geographic markets.
Strategic partnerships with industry leaders.
Securing government contracts.
Adoption of AI in healthcare diagnostics.

APVS面临哪些威胁？

Intense competition from larger companies.
Rapid technological advancements.
Regulatory hurdles and compliance requirements.
Economic downturn affecting customer spending.

APVS的竞争对手是谁？

Averna Technologies Inc. — Offers automated test solutions, competing in the broader technology solutions market. — (AVRI)
Dovarri, Inc. — Likely a private or thinly traded company, potentially offering similar technology solutions. — (DVAR)
IC Real Tech, Inc. — Focuses on surveillance and security technology, overlapping with APVS in the security sector. — (ICRD)
InPlay Technologies, Inc. — Develops semiconductor products, indirectly competing in the technology component space. — (IPLY)
Layla Pharmaceutical Inc. — Operates in the pharmaceutical sector, a different market but potentially utilizing similar imaging technologies. — (LYLP)

Key Metrics

MoonshotScore: 44/100

Company Profile

CEO: William J. Donovan
Headquarters: Leesburg, US
Employees: 3
Founded: 1996

AI Insight

AI analysis pending for APVS

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Applied Visual Sciences, Inc. do?

Applied Visual Sciences, Inc. (APVS) is a technology company that specializes in developing computer-vision detection solutions. Their primary focus is on creating and marketing technologies for the aviation/homeland security and healthcare markets. Their flagship products include PinPoint, designed for automated threat recognition in security environments, and the Signature Mapping platform, which is used in diagnostic radiology and pathology. APVS aims to provide integrated information management solutions to corporations and government agencies, addressing critical needs in security and medical sectors.

What do analysts say about APVS stock?

As of 2026-03-16, there is no available analyst coverage for Applied Visual Sciences, Inc. This lack of coverage is likely due to the company's small market capitalization ($0.00B) and its listing on the OTC market. Investors should conduct their own thorough research and due diligence before investing in APVS, considering the limited information available and the risks associated with OTC stocks. Key valuation metrics include the negative P/E ratio (-0.01) and the volatile beta (-10.35).

What are the main risks for APVS?

Investing in Applied Visual Sciences, Inc. carries several significant risks. The company's limited financial resources and small employee base (3 employees) pose challenges to its ability to compete effectively. The OTC listing results in low trading volume and liquidity, increasing price volatility. Additionally, rapid technological advancements and intense competition in the software industry could threaten APVS's market position. Regulatory hurdles and compliance requirements in the security and healthcare sectors also present ongoing risks.